Morgellons Agrobacterium claims have circulated for years, especially in discussions about GMO crops, genetic transformation, and unusual skin filaments. The theory usually begins with a real scientific observation: Agrobacterium tumefaciens can transfer DNA under certain laboratory conditions. However, some online discussions take a much larger leap by claiming that Agrobacterium must explain Morgellons disease and the formation of keratin and collagen filaments.
The evidence does not support that leap. Researchers once raised Agrobacterium as a possible Morgellons hypothesis, but later work did not confirm it as the cause of the disease.
This article does not mock patients who encountered the theory. Morgellons patients have faced dismissal, stigma, and years of medical neglect. Because many patients feel abandoned by medicine, they naturally search for answers wherever they can find them. Still, patient advocacy requires careful language. A theory can interest researchers without proving causation. A mechanism can work in a lab without explaining a disease in living patients. Likewise, a preliminary finding can raise a question without answering it.
Article Summary
- The 2001 PNAS study is real: researchers showed that Agrobacterium could genetically transform certain human cell lines under laboratory conditions.
- The 2007 Morgellons abstract was preliminary: the authors reported Agrobacterium-related PCR findings in biopsy samples from two Morgellons patients and called for further validation.
- Capability is not causation: showing that Agrobacterium can transform human cells in a lab does not prove it causes Morgellons in living patients.
- Dr. Vitaly Citovsky later clarified the issue: he said his group found no Agrobacterium DNA involved in genetic transformation in the patient samples.
- The responsible conclusion: the Morgellons Agrobacterium theory remains an unconfirmed historical hypothesis, not settled science.
Why the Morgellons Agrobacterium Theory Keeps Coming Back
Agrobacterium is a plant-associated bacterium best known for its unusual ability to transfer DNA into host cells. In plant biology, this natural gene-transfer ability helped make Agrobacterium tumefaciens important in genetic engineering.
Because of that connection, the word “Agrobacterium” became explosive in Morgellons discussions. Once researchers mentioned Agrobacterium in relation to Morgellons, some people connected it to GMO crops, plant DNA, environmental exposure, or genetic modification. In some online spaces, the claim grew even larger: people argued that Morgellons must involve genetic transformation caused by Agrobacterium.
However, the evidence requires more careful handling. Agrobacterium biology is real. The PNAS human-cell study is real. The old Morgellons Agrobacterium abstract is real. Still, combining those pieces does not automatically prove the conclusion being claimed.
What the PNAS Human-Cell Study Actually Showed
Supporters of the Agrobacterium theory often cite a 2001 paper in Proceedings of the National Academy of Sciences titled “Genetic transformation of HeLa cells by Agrobacterium”.
In that study, researchers reported that Agrobacterium could attach to and genetically transform several types of human cells under experimental laboratory conditions. They also found evidence in stably transformed HeLa cells that suggested bona fide T-DNA transfer.
This finding matters. It shows that Agrobacterium can transfer genetic material into certain human cell lines under controlled conditions. However, the study did not investigate Morgellons disease, skin lesions, keratin filaments, collagen filaments, or chronic illness in living patients.
Therefore, the PNAS paper supports biological capability. It does not prove disease causation.
Why Capability Is Not the Same as Causation
The key distinction is simple:
A bacterium can show a capability in a laboratory model without causing a disease in living human skin.
HeLa cells do not behave like normal skin tissue in a living patient. A controlled laboratory transformation system does not recreate a chronic dermatologic disease. Similarly, a possible mechanism does not prove that the mechanism occurs in Morgellons lesions.
To prove causation, researchers would need consistent findings across larger patient groups, appropriate controls, contamination safeguards, tissue-location evidence, proof that genetic transformation occurs in patient cells, and a plausible explanation for how that process would produce the clinical findings seen in Morgellons.
The PNAS paper does not answer those Morgellons-specific questions. It does not show that Agrobacterium transforms keratinocytes or fibroblasts in Morgellons patients. It also does not show that Agrobacterium produces the keratin and collagen filaments described in later Morgellons research.
What the 2007 Morgellons Agrobacterium Abstract Actually Said
The main Morgellons-specific source is a 2007 abstract titled “Contribution of Agrobacterium to Morgellons Disease”, published in Journal of Investigative Medicine. Raphael Stricker, Virginia Savely, A. Zaltsman, and Vitaly Citovsky authored the abstract.
The authors reported PCR testing on skin biopsy samples from two Morgellons patients. According to the abstract, PCR screening detected Agrobacterium genes from both the chromosome and Ti plasmid, including T-DNA, in tissue from both patients.
Those findings raised a question worth investigating. Importantly, though, the abstract used cautious language. It described the results as preliminary and called for further testing to validate the observation. It also said researchers still needed to determine whether Agrobacterium merely resided in affected areas or genetically transformed them.
In other words, the abstract did not prove that Agrobacterium causes Morgellons. It did not prove that GMO crops cause Morgellons. Nor did it prove that Agrobacterium genetically transforms Morgellons patient skin. Instead, it raised a hypothesis and called for more research.
Was This Really a JAMA Dermatology Finding?
Some online discussions describe the Agrobacterium claim as if JAMA Dermatology directly reported that Agrobacterium genetic material appeared in Morgellons lesions. That wording can mislead readers.
The commonly referenced JAMA Network page is an Archives of Dermatology item titled “Cancer in Plants”. It appears in the JAMA Dermatology archive, but it does not serve as the primary Morgellons Agrobacterium study. The Morgellons-specific Agrobacterium item was the 2007 Journal of Investigative Medicine abstract.
This does not mean advocates should ignore the Agrobacterium abstract. Instead, they should describe it accurately. Precision matters, especially when patients already struggle to be taken seriously.
What Dr. Vitaly Citovsky Told Morgellons Survey
Because the Agrobacterium theory began supporting large claims about Morgellons, GMO crops, and genetic transformation, Morgellons Survey previously reached out to Dr. Vitaly Citovsky for clarification. Dr. Citovsky is a SUNY Distinguished Professor in the Department of Biochemistry and Cell Biology at Stony Brook University and one of the authors associated with the early Agrobacterium work.
Here is the clarification that we previously published in our older exploitation article:
GMO plants contain NO Agrobacterium-specific sequences (except for several nucleotides that remain from the T-DNA borders after integration) and thus cannot serve a sources of any bacterial factors or effects.
Dr. Vitaly Citovsky
The bottom line is that we found no DNA of Agrobacterium that is involved in genetic transformation in the patient samples. Also vast experience of thousands of people working with Agrobacterium every day shows no pathogenic effects. Finally based on the well known Agrobacterium biology there is no biological pathway that it has that can be even envisioned to produce morgellons symptoms.
That clarification directly addresses the most common online argument. Yes, Agrobacterium has shown the ability to transfer T-DNA into certain human cell lines under laboratory conditions. However, according to Citovsky’s clarification, the patient samples did not show the Agrobacterium DNA involved in genetic transformation.
That does not mean Morgellons patients imagine their symptoms. It does not mean clinicians should dismiss skin filaments. It does not mean researchers should ignore chronic infection, immune dysfunction, neuropathy, abnormal wound healing, or spirochetal associations.
Rather, it means the Agrobacterium genetic-transformation explanation does not have the support that some people claim.
The Problem With the “Two Receipts” Argument
A common version of the argument goes something like this:
- Receipt one: Morgellons filaments contain human keratin and collagen.
- Receipt two: Agrobacterium can genetically transform human cells in a PNAS study.
- Conclusion: Agrobacterium must explain the abnormal keratin and collagen production in Morgellons.
The first two points may refer to real scientific discussions. However, the conclusion goes too far.
Keratin and collagen findings do not identify Agrobacterium as the cause. Likewise, laboratory transformation of certain human cell lines does not prove transformation of skin cells in Morgellons patients. A preliminary abstract involving two patient samples also cannot establish a confirmed disease mechanism.
Therefore, the careful conclusion is not “logical inevitability.” The careful conclusion is “unconfirmed hypothesis.”
Science does not move from possibility to certainty without replication, controls, mechanism, and clinical confirmation.
What Later Morgellons Research Focused On Instead
Later Morgellons research did not confirm Agrobacterium as the cause of the condition. Instead, much of the published Morgellons literature shifted toward skin filaments, keratin, collagen, epithelial tissue, fibroblasts, Borrelia, and other tick-borne or spirochetal associations.
A 2016 review titled “Morgellons disease: a filamentous borrelial dermatitis” stated plainly that researchers had not confirmed a proposed role for Agrobacterium in Morgellons disease. The same review also noted that the precise mechanism of Morgellons filament formation had not been fully elucidated.
Other Morgellons papers have described filaments as being associated with keratin and collagen expression in human epithelial tissue. A 2015 BMC Dermatology study, “Exploring the association between Morgellons disease and Lyme disease”, discussed Morgellons as a complex skin disorder with ulcerating lesions and protruding or embedded filaments, and reported evidence of spirochetal infection in a studied patient group.
Patients and advocates can discuss that research without claiming more than it proves. The stronger Morgellons conversation does not require the Agrobacterium theory to be true.
Why This Matters for Patient Safety
The problem is not that someone asked whether Agrobacterium might matter. Asking questions is part of science.
The problem begins when a preliminary finding becomes a whole belief system. In some corners of the internet, the Agrobacterium theory has supported claims that GMO crops, environmental spraying, or engineered organisms genetically modified Morgellons patients. Once that story takes hold, patients can become more frightened, more isolated, and less able to speak with clinicians in a way that leads to help.
Unsupported certainty also gives critics an easy target. When the public face of Morgellons becomes nanotechnology, GMO transformation, parasites, bioweapons, or extreme speculation, medical professionals are more likely to dismiss the entire subject. As a result, unsupported theories can harm the very patients they claim to defend.
Morgellons advocacy should be brave, but it also has to be disciplined. Unsupported claims do not make Morgellons more credible. They make it easier to ignore.
Rejecting the Agrobacterium Theory Does Not Mean Rejecting Morgellons
This point matters most.
Saying Agrobacterium has not been proven as the cause of Morgellons is not the same as saying Morgellons patients are delusional. It is not the same as saying clinicians should ignore skin filaments. It is not the same as saying chronic infection, tick-borne exposure, neuropathy, immune dysfunction, or abnormal wound healing should be dismissed.
Instead, it means we should separate the patient experience from unsupported explanations.
A patient can have real lesions, real fibers, real pain, real neurological symptoms, real medical neglect, and real need for evaluation without every internet theory being true.
That is why the responsible position is not:
Agrobacterium definitely causes Morgellons.
And it is not:
Morgellons patients are making everything up.
The responsible position is:
The Agrobacterium finding was preliminary, interesting, and historically important, but researchers did not confirm it as the cause of Morgellons disease. Patients deserve investigation based on evidence, not fear-based certainty.
A Better Path Forward
The Morgellons community does not need more certainty where certainty does not exist. It needs better documentation, better clinical evaluation, better research standards, and better protection from people who exploit patient fear.
That means asking careful questions:
- Are the filaments embedded in tissue or sitting on the surface?
- Were samples collected in a way that reduces contamination?
- Has the patient received evaluation for dermatologic, infectious, neurologic, immune, and environmental contributors?
- Does the patient have evidence of tick exposure, Lyme disease, relapsing fever Borrelia, syphilis, Bartonella, or another condition that could require evaluation?
- Do the claims come from peer-reviewed research, or from fear-based content designed to sell products, attract attention, or control a community narrative?
Those questions help patients. Overconfident Agrobacterium and GMO claims do not.
Bottom Line
Agrobacterium entered Morgellons history because of a small preliminary report. Meanwhile, the PNAS human-cell paper showed that Agrobacterium can genetically transform certain human cell lines under laboratory conditions. Together, those facts may explain why the theory attracted attention.
However, those facts do not prove that Agrobacterium causes Morgellons disease. The 2007 Morgellons abstract raised a question; it did not answer it. Dr. Vitaly Citovsky later clarified that his group found no Agrobacterium DNA involved in genetic transformation in the patient samples. He also said he could not envision a biological pathway by which known Agrobacterium biology would produce Morgellons symptoms.
The Morgellons Agrobacterium theory should therefore remain an unconfirmed historical hypothesis, not settled science. That distinction protects patients from both medical dismissal and fear-based misinformation.
Morgellons patients deserve serious investigation. Serious investigation requires us to reject both lazy dismissal and unsupported certainty.
The evidence does not support telling patients that Morgellons comes from Agrobacterium, GMO crops, or plant genetic engineering. A stronger and safer message is this:
Morgellons is real enough to investigate carefully, and patients are important enough to protect from bad explanations.
Related Morgellons Resources
- The Exploitation of Morgellons: Fear, Scams, Gatekeeping, and Patient Safety
- Morgellons Is Not Nanotechnology
- When It Might Not Be Morgellons: How to Rule Out Lookalikes Without Dismissing Patients
- Morgellons and Lyme Disease: Evidence, Misinformation, and Support Group Red Flags
- Morgellons Doesn’t Automatically Mean Lyme Disease — Here’s Why
- How to Find a Morgellons Doctor
Scientific Sources Mentioned
- Genetic transformation of HeLa cells by Agrobacterium — PNAS
- Genetic transformation of HeLa cells by Agrobacterium — PubMed
- Contribution of Agrobacterium to Morgellons Disease — Journal of Investigative Medicine abstract
- Morgellons disease: a filamentous borrelial dermatitis
- Exploring the association between Morgellons disease and Lyme disease
- Editorial: Cancer in Plants — Archives of Dermatology / JAMA Dermatology archive
Medical disclaimer: This article is for educational and advocacy purposes only. It is not medical advice and does not diagnose or treat any condition. If you have skin lesions, unusual fibers, signs of infection, neurologic symptoms, suspected tick-borne illness, or worsening health symptoms, consider seeking evaluation from a qualified medical professional.
